Earnings History Data for MaxCyte, Inc. (MXCT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
MaxCyte, Inc.
MaxCyte Inc. is a provider of cell-engineering enabling technology and is responsible cell-based therapies. MaxCyte Inc. is headquartered in Gaithersburg, Maryland.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | AH | MXCT | MaxCyte, Inc. | 389.18 | -0.11 | -0.13 | -0.11 | MaxCyte GAAP EPS of -$0.11 beats by $0.01, revenue of $8.2M beats by $0.84M [11/6/2024 5:01 PM] |
3.40 | -0.48 (-12.37%) |
3.88 | 0.0 (0.00%) |
3.15 - 5.55 | 2,151,172 | 350,000 | 43,319 | ||
| 06-08-2024 | AH | MXCT | MaxCyte, Inc. | 473.02 | -0.09 | -0.14 | -0.10 | MaxCyte GAAP EPS of -$0.09 beats by $0.04, revenue of $10.4M beats by $2.47M [8/6/2024 5:17 PM] |
4.07 | -0.38 (-8.65%) |
4.68 | 0.23 (5.17%) |
2.45 - 5.55 | 567,406 | 390,000 | 18,461 | ||
| 07-05-2024 | AH | MXCT | MaxCyte | 400.00 | -0.09 | -0.14 | 0.00 | MaxCyte GAAP EPS of -$0.09 beats by $0.04, revenue of $11.3M beats by $3.79M [5/7/2024 4:28 PM] |
4.63 | 0.70 (17.94%) |
3.94 | 0.01 (0.25%) |
2.45 - 5.55 | 2,714,853 | 430,000 | 2,811 | ||
| 12-03-2024 | AH | MXCT | MaxCyte, Inc. | 407.81 | -0.05 | -0.10 | -0.05 | MaxCyte GAAP EPS of -$0.05 beats by $0.02, revenue of $15.67M beats by $0.61M [3/12/2024 4:12 PM] |
4.16 | 0.18 (4.40%) |
4.14 | 0.16 (4.02%) |
2.45 - 5.55 | 1,008,121 | 670,000 | 1,095 | ||
| 08-11-2023 | AH | MXCT | MaxCyte, Inc. | 362.27 | -0.11 | -0.09 | -0.06 | MaxCyte GAAP EPS of -$0.11 misses by $0.01, revenue of $8M misses by $0.11M [11/8/2023 4:42 PM] |
3.25 | -0.10 (-3.13%) |
3.33 | -0.02 (-0.60%) |
2.45 - 7.41 | 1,027,798 | 960,000 | 13,508 | ||
| 09-08-2023 | AH | MXCT | MaxCyte, Inc. | 439.00 | -0.10 | -0.09 | -0.08 | MaxCyte GAAP EPS of -$0.10 in-line, revenue of $9.04M misses by $1.62M [8/9/2023 4:57 PM] |
3.90 | -0.46 (-10.55%) |
4.11 | -0.25 (-5.73%) |
3.57 - 7.50 | 890,963 | 290,000 | 2,010 | ||
| 10-05-2023 | AH | 4:05 PM ET (May 10) |
MXCT | MaxCyte, Inc. | 487.77 | -0.11 | -0.11 | -0.04 | MaxCyte GAAP EPS of -$0.11, revenue of $8.6M [5/10/2023 4:29 PM] |
3.70 | -0.95 (-20.43%) |
4.08 | -0.57 (-12.26%) |
3.36 - 7.50 | 1,510,225 | 340,000 | 54,057 | |
| 15-03-2023 | AH | 4:05 PM ET (Mar 15) |
MXCT | MaxCyte, Inc. | 479.62 | -0.05 | -0.06 | -0.05 | MaxCyte GAAP EPS of -$0.05 beats by $0.02, revenue of $10.88M misses by $2.25M [3/15/2023 4:11 PM] |
4.48 | 0.28 (6.67%) |
4.20 | 0.0 (0.00%) |
3.36 - 7.76 | 506,702 | 700,000 | 62,720 | |
| 09-11-2022 | AH | 4:05 PM ET (Nov 9) |
MXCT | MaxCyte, Inc. | 689.69 | -0.06 | -0.09 | -0.03 | MaxCyte GAAP EPS of -$0.06 beats by $0.03, revenue of $10.6M beats by $0.17M [11/9/2022 4:41 PM] |
7.08 | 0.99 (16.15%) |
6.49 | 0.39 (6.39%) |
3.36 - 12.99 | 356,311 | 350,000 | 2,208 | |
| 10-08-2022 | AH | 4:05 PM ET (Aug 10) |
MXCT | MaxCyte, Inc. | 532.07 | -0.08 | -0.08 | -0.05 | MaxCyte GAAP EPS of -$0.08 in-line, revenue of $9.6M beats by $0.37M [8/10/2022 4:22 PM] |
5.79 | 0.11 (1.94%) |
5.97 | 0.29 (5.11%) |
3.36 - 17.26 | 697,785 | 230,000 | 476 | |
| 09-05-2022 | AH | 4:05 PM ET (May 9) |
MXCT | MaxCyte, Inc. | 531.91 | -0.04 | -0.07 | 0.00 | MaxCyte GAAP EPS of -$0.04 beats by $0.03, revenue of $11.6M beats by $3.1M [5/9/2022 4:29 PM] |
4.85 | 0.01 (0.21%) |
4.84 | 0.0 (0.00%) |
4.78 - 17.44 | 427,126 | 633,293 | 7,444 | |
| 22-03-2022 | AH | 4:00 PM ET (Mar 22) |
MXCT | MaxCyte, Inc. | 645.79 | -0.05 | -0.05 | 0.00 | MaxCyte GAAP EPS of -$0.05 beats by $0.01, revenue of $10.2M beats by $0.49M [3/22/2022 4:08 PM] |
7.14 | 0.25 (3.55%) |
6.86 | -0.04 (-0.58%) |
5.09 - 17.44 | 962,930 | 750,000 | 3,869 | |
| 10-11-2021 | AH | 4:05 PM ET (Nov 10) |
MXCT | MaxCyte, Inc. | 1,150 | -0.03 | -0.05 | 0.00 | MaxCyte EPS beats by $0.03, beats on revenue [11/10/2021 4:33 PM] |
12.88 | 2.18 (20.37%) |
11.75 | 1.05 (9.81%) |
5.85 - 17.44 | 786,746 | 590,000 | 17,759 | |
| 13-09-2021 | AH | After the close (Sep 13) |
MXCT | MaxCyte, Inc. | 1,650 | -0.05 | -0.05 | 0.00 | MaxCyte EPS beats by $0.01, beats on revenue [9/13/2021 5:43 PM] |
15.43 | 0.12 (0.78%) |
15.28 | -0.03 (-0.20%) |
5.85 - 17.44 | 604,286 | 630,000 | 7,652 | |
|
||||||||||||||||||